The TESCREAL bundle: Eugenics and the promise of utopia through artificial general intelligence
By Timnit Gebru and Émile P. Torres,
First Monday
| 04. 14. 2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can and should be built, researchers are working to create “safe AGI” that is “beneficial for all of humanity.” We argue that, unlike systems with specific applications which can be evaluated following standard engineering principles, undefined systems like “AGI” cannot be appropriately tested for safety. Why, then, is building AGI often framed as an unquestioned goal in the field of AI? In this paper, we argue that the normative framework that motivates much of this goal is rooted in the Anglo-American eugenics tradition of the twentieth century. As a result, many of the very same discriminatory attitudes that animated eugenicists in the past (e.g., racism, xenophobia, classism, ableism, and sexism) remain widespread within the movement to build AGI, resulting in systems that harm marginalized groups and centralize power, while using the language of “safety” and “benefiting humanity” to evade...
Related Articles
Reproductive rights have been a flashpoint in national politics for decades, with the stakes surging after the Supreme Court shredded the right to an abortion. In the current presidential campaign, the battle over abortion has swelled and morphed to encompass in vitro fertilization (IVF), which has now moved rapidly from widely accepted to partisan hot button.
This dramatic shift was highlighted by the February decision of the Alabama Supreme Court that granted personhood rights to frozen IVF embryos, signaling that...
By Annalee Armstrong, BioSpace | 09.11.2024
Complex gene therapies are starting to hit the market but all have faced the same reality: a tepid reception from the healthcare system and a cloudy path to profitability.
It can take about a year for a patient to go...
By Julia Brown, The Conversation | 08.16.2024
With their primary goal to advance scientific knowledge, most scientists are not trained or incentivized to think through the societal implications of the technologies they are developing. Even in genomic medicine, which is geared toward benefiting future patients, time and...
By Smriti Mallapaty, Nature | 09.11.2024
Under his microscope, Jun Wu could see several tiny spheres, each less than 1 millimetre wide. They looked just like human embryos: a dark cluster of cells surrounded by a cavity, and then another ring of cells.
But Wu, a...